{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T05:45:26Z","timestamp":1788587126495,"version":"build-2803163510"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T00:00:00Z","timestamp":1701820800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T00:00:00Z","timestamp":1701820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["K08DK128631"],"award-info":[{"award-number":["K08DK128631"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Exome sequencing (ES) has been used in a variety of clinical settings but there are limited data on its utility for diagnosis and\/or prediction of monogenic liver diseases. We developed a curated list of 502 genes for monogenic disorders associated with liver phenotypes and analyzed ES data for these genes in 758 patients with chronic liver diseases (CLD). For comparison, we examined ES data in 7856 self-declared healthy controls (HC), and 2187 patients with chronic kidney disease (CKD). Candidate pathogenic (P) or likely pathogenic (LP) variants were initially identified in 19.9% of participants, most of which were attributable to previously reported pathogenic variants with implausibly high allele frequencies. After variant annotation and filtering based on population minor allele frequency (MAF\u2009\u2264\u200910<jats:sup>\u20134<\/jats:sup> for dominant disorders and MAF\u2009\u2264\u200910<jats:sup>\u20133<\/jats:sup> for recessive disorders), we detected a significant enrichment of P\/LP variants in the CLD cohort compared to the HC cohort (<jats:italic>X<\/jats:italic><jats:sup>2<\/jats:sup> test OR 5.00, 95% CI 3.06\u20138.18, <jats:italic>p<\/jats:italic> value\u2009=\u20094.5e\u221212). A second-level manual annotation was necessary to capture true pathogenic variants that were removed by stringent allele frequency and quality filters. After these sequential steps, the diagnostic rate of monogenic disorders was 5.7% in the CLD cohort, attributable to P\/LP variants in 25 genes. We also identified concordant liver disease phenotypes for 15\/22 kidney disease patients with P\/LP variants in liver genes, mostly associated with cystic liver disease phenotypes. Sequencing results had many implications for clinical management, including familial testing for early diagnosis and management, preventative screening for associated comorbidities, and in some cases for therapy. Exome sequencing provided a 5.7% diagnostic rate in CLD patients and required multiple rounds of review to reduce both false positive and false negative findings. The identification of concordant phenotypes in many patients with P\/LP variants and no known liver disease also indicates a potential for predictive testing for selected monogenic liver disorders.<\/jats:p>","DOI":"10.1038\/s41598-023-42202-1","type":"journal-article","created":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T17:02:55Z","timestamp":1701882175000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The diagnostic yield of exome sequencing in liver diseases from a curated gene panel"],"prefix":"10.1038","volume":"13","author":[{"given":"Xiao-Fei","family":"Kong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelsie","family":"Bogyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheena","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick R.","family":"Shea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily E.","family":"Groopman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Thomas-Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Cocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hila","family":"Milo Rasouly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beishi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siming","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer M.","family":"Vittorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorna M.","family":"Dove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maddalena","family":"Marasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy C.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth C.","family":"Verna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard J.","family":"Worman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali G.","family":"Gharavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Wattacheril","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,6]]},"reference":[{"issue":"38","key":"42202_CR1","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.15585\/mmwr.mm6638a9","volume":"66","author":"QuickStats","year":"2017","unstructured":"QuickStats. Death Rates* for Chronic Liver Disease and Cirrhosis,\u2020 by Sex and Age Group\u2014National Vital Statistics System, United States, 2000 and 2015. MMWR Morb. Mortal. Wkly. Rep. 66(38), 1031. https:\/\/doi.org\/10.15585\/mmwr.mm6638a9 (2017).","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"issue":"2","key":"42202_CR2","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.gene.2015.10.009","volume":"574","author":"JC Barton","year":"2015","unstructured":"Barton, J. C., Edwards, C. Q. & Acton, R. T. HFE gene: Structure, function, mutations, and associated iron abnormalities. Gene 574(2), 179\u2013192. https:\/\/doi.org\/10.1016\/j.gene.2015.10.009 (2015).","journal-title":"Gene"},{"issue":"4","key":"42202_CR3","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/ng0896-399","volume":"13","author":"JN Feder","year":"1996","unstructured":"Feder, J. N. et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat. Genet. 13(4), 399\u2013408. https:\/\/doi.org\/10.1038\/ng0896-399 (1996).","journal-title":"Nat. Genet."},{"issue":"6174","key":"42202_CR4","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1126\/science.1249484","volume":"343","author":"JN Honeyman","year":"2014","unstructured":"Honeyman, J. N. et al. Detection of a recurrent DNAJB1-PRKACA chimeric transcript in fibrolamellar hepatocellular carcinoma. Science (80- ) 343(6174), 1010\u20131014. https:\/\/doi.org\/10.1126\/science.1249484 (2014).","journal-title":"Science (80- )"},{"issue":"8","key":"42202_CR5","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1084\/jem.20190669","volume":"216","author":"S Belkaya","year":"2019","unstructured":"Belkaya, S. et al. Inherited IL-18BP deficiency in human fulminant viral hepatitis. J. Exp. Med. 216(8), 1777\u20131790. https:\/\/doi.org\/10.1084\/jem.20190669 (2019).","journal-title":"J. Exp. Med."},{"issue":"1","key":"42202_CR6","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ajhg.2015.05.009","volume":"97","author":"TB Haack","year":"2015","unstructured":"Haack, T. B. et al. Biallelic mutations in NBAS cause recurrent acute liver failure with onset in infancy. Am. J. Hum. Genet. 97(1), 163\u2013169. https:\/\/doi.org\/10.1016\/j.ajhg.2015.05.009 (2015).","journal-title":"Am. J. Hum. Genet."},{"key":"42202_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/J.AJHG.2019.05.011","author":"MA Cousin","year":"2019","unstructured":"Cousin, M. A. et al. RINT1 bi-allelic variations cause infantile-onset recurrent acute liver failure and skeletal abnormalities. Am. J. Hum. Genet. https:\/\/doi.org\/10.1016\/J.AJHG.2019.05.011 (2019).","journal-title":"Am. J. Hum. Genet."},{"issue":"6","key":"42202_CR8","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1002\/hep.28499","volume":"63","author":"S Vilarinho","year":"2016","unstructured":"Vilarinho, S. et al. Recurrent recessive mutation in deoxyguanosine kinase causes idiopathic noncirrhotic portal hypertension. Hepatology 63(6), 1977\u20131986. https:\/\/doi.org\/10.1002\/hep.28499 (2016).","journal-title":"Hepatology"},{"key":"42202_CR9","doi-asserted-by":"publisher","DOI":"10.1084\/JEM.20201745","author":"K Drzewiecki","year":"2021","unstructured":"Drzewiecki, K. et al. GIMAP5 maintains liver endothelial cell homeostasis and prevents portal hypertension. J. Exp. Med. https:\/\/doi.org\/10.1084\/JEM.20201745 (2021).","journal-title":"J. Exp. Med."},{"issue":"7","key":"42202_CR10","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1056\/NEJMsr1809937","volume":"381","author":"JC Denny","year":"2019","unstructured":"Denny, J. C. et al. The \u201cAll of Us\u201d research program. N. Engl. J. Med. 381(7), 668\u2013676. https:\/\/doi.org\/10.1056\/NEJMsr1809937 (2019).","journal-title":"N. Engl. J. Med."},{"key":"42202_CR11","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaf6814","author":"FE Dewey","year":"2016","unstructured":"Dewey, F. E. et al. Distribution and clinical impact of functional variants in 50,726 whole-exome sequences from the DiscovEHR study. Science (80- ) https:\/\/doi.org\/10.1126\/science.aaf6814 (2016).","journal-title":"Science (80- )"},{"issue":"2","key":"42202_CR12","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.jhep.2007.09.013","volume":"48","author":"XF Kong","year":"2008","unstructured":"Kong, X. F. et al. Identification of a ferrochelatase mutation in a Chinese family with erythropoietic protoporphyria. J. Hepatol. 48(2), 375\u2013379. https:\/\/doi.org\/10.1016\/j.jhep.2007.09.013 (2008).","journal-title":"J. Hepatol."},{"issue":"1","key":"42202_CR13","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1471-2350-12-6","volume":"12","author":"X-H Li","year":"2011","unstructured":"Li, X.-H. et al. Clinical and molecular characterization of Wilson\u2019s disease in China: Identification of 14 novel mutations. BMC Med. Genet. 12(1), 6. https:\/\/doi.org\/10.1186\/1471-2350-12-6 (2011).","journal-title":"BMC Med. Genet."},{"issue":"2","key":"42202_CR14","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.gene.2013.03.130","volume":"524","author":"X-F Kong","year":"2013","unstructured":"Kong, X.-F. et al. Recurrent porphyria attacks in a Chinese patient with a heterozygous PBGD mutation. Gene 524(2), 401\u2013402. https:\/\/doi.org\/10.1016\/j.gene.2013.03.130 (2013).","journal-title":"Gene"},{"issue":"S1","key":"42202_CR15","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1016\/j.jhep.2015.02.025","volume":"62","author":"TH Karlsen","year":"2015","unstructured":"Karlsen, T. H., Lammert, F. & Thompson, R. J. Genetics of liver disease: From pathophysiology to clinical practice. J. Hepatol. 62(S1), S6\u2013S14. https:\/\/doi.org\/10.1016\/j.jhep.2015.02.025 (2015).","journal-title":"J. Hepatol."},{"issue":"4","key":"42202_CR16","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1111\/LIV.15185","volume":"42","author":"S Pelusi","year":"2022","unstructured":"Pelusi, S. et al. Clinical exome sequencing for diagnosing severe cryptogenic liver disease in adults: A case series. Liver Int. 42(4), 864\u2013870. https:\/\/doi.org\/10.1111\/LIV.15185 (2022).","journal-title":"Liver Int."},{"key":"42202_CR17","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1016\/j.jhep.2021.01.045","volume":"74","author":"R Liebe","year":"2021","unstructured":"Liebe, R. et al. Diagnosis and management of secondary causes of steatohepatitis. J. Hepatol. 74, 1455\u20131471. https:\/\/doi.org\/10.1016\/j.jhep.2021.01.045 (2021).","journal-title":"J. Hepatol."},{"issue":"5","key":"42202_CR18","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1002\/ajh.23153","volume":"87","author":"C Masserot-Lureau","year":"2012","unstructured":"Masserot-Lureau, C. et al. Incidence of liver abnormalities in Fanconi anemia patients. Am. J. Hematol. 87(5), 547\u2013549. https:\/\/doi.org\/10.1002\/ajh.23153 (2012).","journal-title":"Am. J. Hematol."},{"issue":"6","key":"42202_CR19","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1002\/HEP.32539","volume":"76","author":"D Sharma","year":"2022","unstructured":"Sharma, D. et al. Tip of the iceberg: A comprehensive review of liver disease in Inborn errors of immunity. Hepatology 76(6), 1845\u20131861. https:\/\/doi.org\/10.1002\/HEP.32539 (2022).","journal-title":"Hepatology"},{"issue":"1","key":"42202_CR20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.7326\/M18-1241","volume":"170","author":"HM Rasouly","year":"2019","unstructured":"Rasouly, H. M. et al. The burden of Candidate pathogenic variants for kidney and genitourinary disorders emerging from exome sequencing. Ann. Intern. Med. 170(1), 11\u201321. https:\/\/doi.org\/10.7326\/M18-1241 (2019).","journal-title":"Ann. Intern. Med."},{"issue":"2","key":"42202_CR21","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1056\/nejmoa1806891","volume":"380","author":"EE Groopman","year":"2019","unstructured":"Groopman, E. E. et al. Diagnostic utility of exome sequencing for kidney disease. N. Engl. J. Med. 380(2), 142\u2013151. https:\/\/doi.org\/10.1056\/nejmoa1806891 (2019).","journal-title":"N. Engl. J. Med."},{"key":"42202_CR22","doi-asserted-by":"publisher","DOI":"10.7326\/M18-1241","author":"H Milo Rasouly","year":"2019","unstructured":"Milo Rasouly, H. et al. The burden of candidate pathogenic variants for kidney and genitourinary disorders emerging from exome sequencing. Ann. Intern. Med. https:\/\/doi.org\/10.7326\/M18-1241 (2019).","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"42202_CR23","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/J.AJHG.2018.11.012","volume":"104","author":"N Whiffin","year":"2019","unstructured":"Whiffin, N. et al. Using high-resolution variant frequencies empowers clinical genome interpretation and enables investigation of genetic architecture. Am. J. Hum. Genet. 104(1), 187\u2013190. https:\/\/doi.org\/10.1016\/J.AJHG.2018.11.012 (2019).","journal-title":"Am. J. Hum. Genet."},{"issue":"10","key":"42202_CR24","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1038\/GIM.2017.26","volume":"19","author":"N Whiffin","year":"2017","unstructured":"Whiffin, N. et al. Using high-resolution variant frequencies to empower clinical genome interpretation. Genet. Med. 19(10), 1151\u20131158. https:\/\/doi.org\/10.1038\/GIM.2017.26 (2017).","journal-title":"Genet. Med."},{"issue":"1","key":"42202_CR25","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/S41436-018-0044-2","volume":"21","author":"V Shashi","year":"2019","unstructured":"Shashi, V. et al. A comprehensive iterative approach is highly effective in diagnosing individuals who are exome negative. Genet. Med. 21(1), 161\u2013172. https:\/\/doi.org\/10.1038\/S41436-018-0044-2 (2019).","journal-title":"Genet. Med."},{"key":"42202_CR26","doi-asserted-by":"publisher","DOI":"10.14740\/gr609e","author":"A Syed","year":"2014","unstructured":"Syed, A. & Hajira, A. A comprehensive review of progressive familial intrahepatic cholestasis (PFIC): Genetic disorders of hepatocanalicular transporters. Gastroenterol. Res. https:\/\/doi.org\/10.14740\/gr609e (2014).","journal-title":"Gastroenterol. Res."},{"issue":"5","key":"42202_CR27","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/J.AJHG.2022.03.015","volume":"109","author":"J Devane","year":"2022","unstructured":"Devane, J. et al. Progressive liver, kidney, and heart degeneration in children and adults affected by TULP3 mutations. Am. J. Hum. Genet. 109(5), 928\u2013943. https:\/\/doi.org\/10.1016\/J.AJHG.2022.03.015 (2022).","journal-title":"Am. J. Hum. Genet."},{"issue":"5","key":"42202_CR28","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1038\/S41436-018-0288-X","volume":"21","author":"S Maddirevula","year":"2019","unstructured":"Maddirevula, S. et al. Identification of novel loci for pediatric cholestatic liver disease defined by KIF12, PPM1F, USP53, LSR, and WDR83OS pathogenic variants. Genet. Med. 21(5), 1164\u20131172. https:\/\/doi.org\/10.1038\/S41436-018-0288-X (2019).","journal-title":"Genet. Med."},{"issue":"4","key":"42202_CR29","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/J.JHEP.2015.11.027","volume":"64","author":"BGP Koot","year":"2016","unstructured":"Koot, B. G. P., Alders, M., Verheij, J., Beuers, U. & Cobben, J. M. A de novo mutation in KCNN3 associated with autosomal dominant idiopathic non-cirrhotic portal hypertension. J. Hepatol. 64(4), 974\u2013977. https:\/\/doi.org\/10.1016\/J.JHEP.2015.11.027 (2016).","journal-title":"J. Hepatol."},{"key":"42202_CR30","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/j.ajhg.2019.04.012","volume":"104","author":"CK Bauer","year":"2019","unstructured":"Bauer, C. K. et al. Gain-of-function mutations in KCNN3 encoding the small-conductance Ca 2\u00fe-activated K \u00fe channel SK3 cause Zimmermann\u2013Laband syndrome. Am. J. Hum. Genet. 104, 1139\u20131157. https:\/\/doi.org\/10.1016\/j.ajhg.2019.04.012 (2019).","journal-title":"Am. J. Hum. Genet."},{"issue":"9","key":"42202_CR31","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1016\/J.AJHG.2021.06.020","volume":"108","author":"Z Stark","year":"2021","unstructured":"Stark, Z. et al. Scaling national and international improvement in virtual gene panel curation via a collaborative approach to discordance resolution. Am. J. Hum. Genet. 108(9), 1551\u20131557. https:\/\/doi.org\/10.1016\/J.AJHG.2021.06.020 (2021).","journal-title":"Am. J. Hum. Genet."},{"issue":"3","key":"42202_CR32","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1002\/(SICI)1098-1004(1999)13:3<210::AID-HUMU5>3.0.CO;2-0","volume":"13","author":"RT Taggart","year":"1999","unstructured":"Taggart, R. T., Smail, D., Apolito, C. & Vladutiu, G. D. Novel mutations associated with carnitine palmitoyltransferase II deficiency. Hum. Mutat. 13(3), 210\u2013220. https:\/\/doi.org\/10.1002\/(SICI)1098-1004(1999)13:3%3c210::AID-HUMU5%3e3.0.CO;2-0 (1999).","journal-title":"Hum. Mutat."},{"issue":"D1","key":"42202_CR33","doi-asserted-by":"publisher","first-page":"D865","DOI":"10.1093\/nar\/gkw1039","volume":"45","author":"S K\u00f6hler","year":"2017","unstructured":"K\u00f6hler, S. et al. The human phenotype ontology in 2017. Nucleic Acids Res. 45(D1), D865\u2013D876. https:\/\/doi.org\/10.1093\/nar\/gkw1039 (2017).","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"42202_CR34","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s10545-016-0012-4","volume":"40","author":"D Marques-da-Silva","year":"2017","unstructured":"Marques-da-Silva, D. et al. Liver involvement in congenital disorders of glycosylation (CDG). A systematic review of the literature. J. Inherit. Metab. Dis. 40(2), 195\u2013207. https:\/\/doi.org\/10.1007\/s10545-016-0012-4 (2017).","journal-title":"J. Inherit. Metab. Dis."},{"key":"42202_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/4761962","volume":"2017","author":"M Kulecka","year":"2017","unstructured":"Kulecka, M. et al. Clinical applicability of whole-exome sequencing exemplified by a study in young adults with the advanced cryptogenic cholestatic liver diseases. Gastroenterol. Res. Pract. 2017, 1\u20138. https:\/\/doi.org\/10.1155\/2017\/4761962 (2017).","journal-title":"Gastroenterol. Res. Pract."},{"issue":"4","key":"42202_CR36","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.cld.2017.06.001","volume":"21","author":"EA Schonfeld","year":"2017","unstructured":"Schonfeld, E. A. & Brown, R. S. Genetic testing in liver disease: What to order, in whom, and when. Clin. Liver Dis. 21(4), 673\u2013686. https:\/\/doi.org\/10.1016\/j.cld.2017.06.001 (2017).","journal-title":"Clin. Liver Dis."},{"issue":"5","key":"42202_CR37","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.mayocp.2017.03.002","volume":"92","author":"MC Stephens","year":"2017","unstructured":"Stephens, M. C., Boardman, L. A. & Lazaridis, K. N. Individualized medicine in gastroenterology and hepatology. Mayo Clin. Proc. 92(5), 810\u2013825. https:\/\/doi.org\/10.1016\/j.mayocp.2017.03.002 (2017).","journal-title":"Mayo Clin. Proc."},{"issue":"2","key":"42202_CR38","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1002\/lt.24964","volume":"24","author":"E Nicastro","year":"2018","unstructured":"Nicastro, E. & D\u2019Antiga, L. Next generation sequencing in pediatric hepatology and liver transplantation. Liver Transplant. 24(2), 282\u2013293. https:\/\/doi.org\/10.1002\/lt.24964 (2018).","journal-title":"Liver Transplant."},{"key":"42202_CR39","doi-asserted-by":"publisher","unstructured":"Pericleous, M., Kelly, C., Ala, A. & Schilsky, M. L. The epidemiology of rare hereditary metabolic liver diseases. In Clinical Epidemiology of Chronic Liver Diseases 307\u2013330 (Springer, 2018). https:\/\/doi.org\/10.1007\/978-3-319-94355-8_17.","DOI":"10.1007\/978-3-319-94355-8_17"},{"issue":"7616","key":"42202_CR40","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nature19057","volume":"536","author":"M Lek","year":"2016","unstructured":"Lek, M. et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature 536(7616), 285\u2013291. https:\/\/doi.org\/10.1038\/nature19057 (2016).","journal-title":"Nature"},{"issue":"23","key":"42202_CR41","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1056\/NEJMSR1406261","volume":"372","author":"HL Rehm","year":"2015","unstructured":"Rehm, H. L. et al. ClinGen: The clinical genome resource. N. Engl. J. Med. 372(23), 2235\u20132242. https:\/\/doi.org\/10.1056\/NEJMSR1406261 (2015).","journal-title":"N. Engl. J. Med."},{"key":"42202_CR42","doi-asserted-by":"publisher","DOI":"10.1101\/2020.06.08.136507","author":"Z Ren","year":"2020","unstructured":"Ren, Z., Povysil, G. & Goldstein, D. B. ATAV: A comprehensive platform for population-scale genomic analyses. bioRxiv https:\/\/doi.org\/10.1101\/2020.06.08.136507 (2020).","journal-title":"bioRxiv"},{"issue":"7809","key":"42202_CR43","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","volume":"581","author":"KJ Karczewski","year":"2020","unstructured":"Karczewski, K. J. et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature 581(7809), 434\u2013443. https:\/\/doi.org\/10.1038\/s41586-020-2308-7 (2020).","journal-title":"Nature"},{"issue":"5","key":"42202_CR44","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards, S. et al. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 17(5), 405\u2013424. https:\/\/doi.org\/10.1038\/gim.2015.30 (2015).","journal-title":"Genet. Med."},{"issue":"2","key":"42202_CR45","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/gim.2016.190","volume":"19","author":"SS Kalia","year":"2017","unstructured":"Kalia, S. S. et al. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): A policy statement of the American College of Medical Genetics and Genomics. Genet. Med. 19(2), 249\u2013255. https:\/\/doi.org\/10.1038\/gim.2016.190 (2017).","journal-title":"Genet. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-42202-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-42202-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-42202-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T17:19:58Z","timestamp":1701883198000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-42202-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,6]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["42202"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-42202-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,6]]},"assertion":[{"value":"20 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Xiao-Fei Kong was supported by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health under Award Number K08DK128631. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Dr. Gharavi has received research funding from the Renal Research Institute and Natera and has served as a consultant for Goldfinch Bio. All other authors declare no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21540"}}